According to studies, the Chinese vaccine protects 79% of the delta variant

Chinese pharmaceutical company Clover Biopharmaceuticals has announced that it has developed a vaccine whose studies show a 79% effectiveness in protecting patients from complications of any severity caused by the delta variant SARS-CoV-2, local media reported today.

Similarly, the pharmaceutical company – which plans to deliver 414 million doses to COVAX – said the vaccine, called SCB-19 and protein-based, was 92% and 59% effective against gamma and its variants, respectively.

Source link...